| ASSET | YEAR | % RETURN |
|---|---|---|
Soleno Therapeutics (SLNO) | 2014 | -70.75% |
Soleno Therapeutics (SLNO) | 2015 | 28.47% |
Soleno Therapeutics (SLNO) | 2016 | -56.62% |
Soleno Therapeutics (SLNO) | 2017 | -55.59% |
Soleno Therapeutics (SLNO) | 2018 | -3.93% |
Soleno Therapeutics (SLNO) | 2019 | 71.93% |
Soleno Therapeutics (SLNO) | 2020 | -32.28% |
Soleno Therapeutics (SLNO) | 2021 | -79.08% |
Soleno Therapeutics (SLNO) | 2022 | -68.94% |
Soleno Therapeutics (SLNO) | 2023 | 1,825.84% |
Soleno Therapeutics (SLNO) | 2024 | 11.57% |
Soleno Therapeutics (SLNO) | 2025 | 48.46% |
